BioPharma Credit (BPCR) announce that it, through its fully owned subsidiary, together with BioPharma Credit Investments V (Master) LP (“BioPharma-V” and jointly with the Company the “Lenders”) has entered into a US$300m definitive senior secured loan agreement with LumiraDx Investment and LumiraDx Group. BPCR will invest $150m and BioPharma-V will invest an additional $150m. COVID-19 antibody […]
In QuotedData’s morning briefing 24 March 2021 – BMO Private Equity (BPET) announced that the software company, Dotmatics, in which it has a holding, has entered an agreement for its sale to US-based company Insightful Science. The transaction is expected to complete early in Q2. The investment is led by Scotland based growth equity investor […]
Princess Private Equity (PEYS) has reported final results to 31 December 2020, with highlights that include: NAV increased to EUR 13.35 per share, representing a total return of +10.0% for the year. Share price total return over the same period was +12.4%. PEYS paid a total dividend of EUR 0.435 per share during the year, […]
In QuotedData’s morning briefing 22 March 2021 – Flexible investment sector company, New Star (NSI), reported interim results to 31 December 2020, delivering a total NAV return of 8.7% and a total market return of 15.1%. NSI benefited from its allocations to UK smaller stocks and emerging market equities but its allocations to dollar cash and gold […]
During The Schiehallion Fund’s (MNTN’s) financial year to 31 January 2021, its share price and NAV returned 48.1% and 42.3%. Over the period from 27 March 2019 (launch date) to 31 January 2021, MNTN’s share price and NAV returned 80.0% and 47.5%. When the MNTN was launched, raising gross proceeds of US$477m, its board said […]
Baillie Gifford Shin Nippon (BGS) had an outstanding year to 31 January 2021, with the NAV increasing by 34.0% on a total return basis, compared to a 5.3% rise in the comparative MSCI Japan Small Cap Index. Top performers and main detractors Highlights from the portfolio over the year included: “Online legal portal Bengo4.com was the top positive […]
JPMorgan Claverhouse (JCH) annual results period to 31 December 2020 brought a -10.8% total NAV return. This compares with a total return for the same period from the company’s benchmark, the FTSE all-share index, of -9.8%. JCH says its returns were caused principally by being geared at the time of the steep market fall in the early […]
Fidelity European’s (FEV’s) NAV increased by 9.7% on a total return basis over the year ended 31 December 2020. This represented an outperformance of its benchmark, the FTSE World Europe (ex UK) index, which returned 8.6%. Important points of note from the corporate and manager level were the appointment of Marcel Stotzel as a co-manager alongside […]
In QuotedData’s morning briefing 17 March 2021 – UK Mortgages’s (UKML’s) interim results to 31 December 2020 delivered a 7.7% total NAV return. Chairman, Christopher Waldron, said the following in his notes: “Clearly, since those early days of the COVID-19 pandemic our worst fears over the extent of mortgage holidays and the consequences of other forbearance […]
Allianz Technology (ATT) had an excellent year, with total NAV and share price returns of 76.1% and 80.3%, over its financial year-end to 31 December 2020. In a great year for technology overall, ATT shone, with its NAV return outperforming its benchmark, the Dow Jones world technology index, by 34.4%. The top 10 holdings in ATT’s […]
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated